Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO) which expanded later to be an integrated
Syngene International Ltd Q1FY24; 26% rise in Profits
Categories
Health Care
Novartis India Ltd Q1FY24; 62% fall in Profits
Novartis India Ltd is primarily engaged in the Business of Wholesale of pharmaceuticals and medical goods.It imports various medicines to India from
Shalby Ltd Q1FY24; 5% rise in Profits
Shalby Ltd is engaged in healthcare delivery space in India. It operates a chain of multi-specialty hospitals across India. The business of
Narayana Hrudayalaya: Play on Affordability?
“Our existing health insurance system operates on a fee-for-service model. It will pay you when you get sick, does nothing for you
SastaSundar Ventures – A new player in the e-pharmacy space
“We spent last few years building most efficient Digital Healthcare Platform in terms of Cost, Consumer Experience and Capital. The continued focus
Apollo Hospital: The one stop healthcare service
“At a time when the world is realizing the importance of prevention more than ever before, it is a matter of pride
Piramal Pharma Q4FY23 Earnings Story
Piramal Pharma Limited (PPL) is part of the Piramal group of companies. The company operates through 3 major segments(1) Contract development and
Panacea Biotec Q4FY23 Earnings Story
Panacea Biotec was set up in the year 1984, under the name of Panacea Drugs Private Limited and was publicly listed in
Natco Pharma Q4FY23 Earnings Story
NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products
Metropolis Healthcare Q4FY23 Earnings Story
Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South
MedPlus Health Services Q4FY23 Earnings
India’s Leading Pharmacy company MedPlus Health Services is the second-largest pharmacy retailer in India in terms of revenue and number of stores.
Krishna Institute of Medical Sciences Q4FY23 Earnings
In terms of the number of patients served and services provided, Krishna Medical Institution Ltd (KIMS), which was founded in 1973, is
Apollo Hospitals Enterprise Limited Q4 FY23 Earnings Conference Call Insights
Key highlights from Apollo Hospitals Enterprise Limited (APOLLOHOSP) Q4 FY23 Earnings Concall Management Update: [00:08:21] APOLLOHOSP said it has made significant progress
Venus Remedies Ltd Q4FY23 results out, revenue grows by over 10%
Venus Remedies Ltd is an Indian Pharmaceutical company with a presence in domestic and international markets. It is primarily engaged in the
Jubilant Pharmova Q4FY23 Earnings Story
The three business components of Jubilant Pharmova Ltd, which include medicines, contract research and development services, and patented new therapies, make up
Apollo Hospitals Enterprise Limited (APOLLOHOSP) Q4 FY23 Earnings Concall Transcript
Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) Q4 FY23 Earnings Concall dated May. 31, 2023 Corporate Participants: Mayank Vaswani -- Investor Relations Suneeta Reddy
Jubilant Pharmova Q4FY23; Reported Losses
Jubilant Pharmova Ltd.’s revenue in Q4FY23 rose 10% to ₹ 1,678 crores. Consolidated Loss After Tax came at ₹ 101 crores in
Hester Biosciences Limited (HESTERBIO) Q4 FY23 Earnings Concall Transcript
Hester Biosciences Limited (NSE:HESTERBIO) Q4 FY23 Earnings Concall dated May. 18, 2023. Corporate Participants: Bimal Lalitsingh Goculdas -- Chief Executive Officer Analysts: Abhishek Mehra -- TIL
Hester Biosciences Limited (HESTERBIO) Q4 FY23 Earnings Concall Transcript
Hester Biosciences Limited (NSE:HESTERBIO) Q4 FY23 Earnings Concall dated May. 17, 2023. Corporate Participants: Unidentified Speaker -- Analysts: Nirav Seksaria -- Living Root Capital --
AMI Organics Ltd (AMIORG) Q4 FY23 Earnings Concall Transcript
AMI Organics Ltd (NSE:AMIORG) Q4 FY23 Earnings Concall dated May. 15, 2023. Corporate Participants: Bhavin Shah -- Chief Financial Officer Nareshkumar Ramjibhai Patel -- Executive Chairman
Dr Lal PathLabs Ltd (LALPATHLAB) Q4 FY23 Earnings Concall Transcript
Dr Lal PathLabs Ltd (NSE:LALPATHLAB) Q4 FY23 Earnings Concall dated May. 11, 2023. Corporate Participants: Hon. Brig. Dr. Arvind Lal -- Executive Chairman Om